Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. The company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. Our business includes medical technology innovation centers and a unique manufacturing supply chain across both China and North America. Through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
Looking for a particular Athenex employee's phone or email?
Athenex Questions
The Athenex annual revenue was $21.8 billion in 2026.
Johnson Lau is the Chairman and CEO of Athenex.
84 people are employed at Athenex.
Athenex is based in Buffalo, New York.
The NAICS codes for Athenex are [325, 32541, 32, 3254, 325414, 55].
The SIC codes for Athenex are [283, 28].
Top Athenex Employees
-
Johnson Lau
Chairman and CEO at Athenex
California, United States25+ -
Tim Call
Sr. Director, Manufacturing at Athenex
Buffalo, NY, US35+ -
John Andre
Senior Director of Regulatory Affairs at Athenex
Florida, United States35+ -
Claire Hostetler
Area Sales Director at Athenex
Nashville, TN, US21 -
Mark Forell
Sr. Director of Engineering at Athenex
New York, United States12 -
Barbara Brand
Director, Medical Communications at Athenex
Fair Lawn, NJ, US11
Related Companies
